Regulation of the Fanconi anemia pathway by monoubiquitination

Seminars in Cancer Biology

Volumn 13, Issue 1, 2003, Pages 77-82

  Gregory, Richard C ^a   Taniguchi, Toshiyasu ^a   D'Andrea, Alan D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Ataxia telangiectasia; DNA repair; Fanconi anemia; Monoubiquitin

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; MOLECULAR CLONING; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037328823     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(02)00102-5     Document Type: Article

References (41)

1. Wang J.Y.J. New Link in a web of human genes. Nature. 405:2000;404-405.
2. Pickart C.M. Ubiquitin enters the new millennium. Mol. Cell. 8:2001;499-504.
3. Joenje H.et al. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2:2001;446-459.
4. Grompe M.et al. Fanconi anemia and DNA repair. Hum. Mol. Genet. 10:2001;2253-2259.
5. Duckworth-Rysiecki G.et al. Effects on ionizing radiation on cells from Fanconi's anemia patients. Cancer Res. 45:1985;416.
6. Carreau M.et al. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat. Res. 435:1999;103-109.
7. Joenje H.et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am. J. Hum. Genet. 67:2000;759-762.
8. Timmers C.et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell. 7:2001;241-248.
9. Garcia-Higuera I.et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 7:2001;249-262.
10. de Winter J.P.et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2000;2665-2674.
11. Medhurst A.L.et al. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10:2001;423-429.
12. Garcia-Higuera I.et al. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19:1999;4866-4873.
13. Yamashita T.et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. PNAS. 95:1998;13085-13090.
14. Siddique M.A.et al. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1. Exp. Hematol. 29:2000;1448-1455.
15. Rahman N.et al. The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:1998;95-121.
16. Moynahan M.E.et al. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
17. Xu B.et al. Involvement of BRCA1 in S-phase and G2-phase checkpoints after ionizing radiation. Mol. Cell Biol. 21:2001;3445-3450.
18. Joazeiro C.A.P.et al. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102:2000;549-552.
19. Ruffner H.et al. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5134-5139.
20. Scully R.et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 88:1997;265-275.
21. Zhong Q.et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science. 285:1999;747-750.
22. Paull T.T.et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
23. Taniguchi T, et al. S phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, in press.
24. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 79:1994;13-21.
25. Huibregtse J.M.et al. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. U.S.A. 92:1985;2563-2567.
26. Lorick K.et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. PNAS. 96:1999;11364-11369.
27. Patterson C. A new gun in town: the U box is a ubiquitin ligase domain. Sci. STKE. 2002:2002;E4.
28. Mueller R.D.et al. Identification of ubiquitinated histones 2A and 2B in Physarum polycephalum. J. Biol. Chem. 260:1985;5147-5153.
29. Shih S.C.et al. Monoubiquitin carries a novel internalization signal that is appended to activated receptors. EMBO J. 19:2000;187-198.
30. ll 250, a mediator of activation of gene expression in Drosophila. Science. 289:2000;2357-2360.
31. Kaiser P.et al. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF (Met30)-mediated inactivation of the transcription factor Met4. Cell. 102:2000;303-314.
32. Vassilev A.P.et al. The levels of ubiquitinated histone H2A ae highly upregulated in transformed human cells: partial colocalization of uH2A clusters and PCNA/cyclin foci in a fraction of cells in S-phase. J. Cell Sci. 108:1995;1205-1215.
33. Robzyk K.et al. Rad6-dependent ubiquitination of histone H2B in yeast. Science. 287:2000;501-504.
34. Scully R.et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435.
35. Cortez W.J.et al. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
36. Li S.et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 406:2000;210-215.
37. Ruffner H.et al. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol. Cell Biol. 19:1999;4843-4854.
38. Hashizume R.et al. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276:2001;14537-14540.
39. Taniguchi T.et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109:2002;459-472.
40. Ciechanover A.et al. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays. 22:2000;442-451.
41. Wang Y.et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939.